We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Male Sexual Development Protein Identified

By Biotechdaily staff writers
Posted on 11 Jun 2002
Researchers studying developing mouse embryos have found that a protein called Desert Hedgehog (DHH) is required to induce the differentiation of Leydig cells, the site of synthesis of the male hormone testosterone. More...
This finding was published in the June 1, 2002, issue of Genes & Development.

DHH is one of three mammalian homologs of Hedgehog, which was originally identified in the Drosophila fruit fly, where it regulates body pattern formation. While all three homologs have been found to have important signaling functions during development of the mammalian embryo, the current study established the primary role of DHH in inducing secondary male sex characteristics.

Investigators at Duke University Medical Center (Durham, NC, USA; www.mc.duke.edu) found that DHH and its receptor, Patched 1, were specifically expressed in XY (male) embryos in a temporally and spatially restricted pattern that corresponded to the correct time and place for fetal Leydig cell differentiation. Then, examining males from a strain of mice genetically engineered to lack DHH, they found that the Leydig cell precursors appeared intact, but the mice displayed defects in the differentiation of the precursors into Leydig cells.

While all fetal Leydig cells express the DHH receptor, Patched 1, not all Patched 1-expressing cells become fetal Leydig cells. This finding points to the existence of other signaling pathways that may act in conjunction with DHH/Patched 1 to fine-tune the specification of fetal Leydig cell fate.



Related Links:
Duke U. Medical Center

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
New
Gold Member
POCT RT-qPCR Analyzer
BG-X6
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.